secwatch / observer
8-K filed October 17, 2023, 7:59 PM ET CIK 0001426332
other confidence high sentiment neutral materiality 0.60

NGM Biopharmaceuticals reprices underwater stock options for employees, effective after Q3 2023 filing

NGM BIOPHARMACEUTICALS INC

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Siobhan Nolan Mangini

President and Chief Financial Officer
NGM BIOPHARMACEUTICALS INC
Effective
2023-12-01
Filed
October 17, 2023, 7:59 PM ET
Siobhan Nolan Mangini who, as previously announced by the Company, is stepping down as President and Chief Financial Officer on December 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Siobhan Nolan Mangini departed as President and Chief Financial Officer at NGM BIOPHARMACEUTICALS INC.

Action
stepping down
Role
President and Chief Financial Officer
Exact text from the filing
Siobhan Nolan Mangini who, as previously announced by the Company, is stepping down as President and Chief Financial Officer on December 1, 2023.
View on SEC.gov
Source: SEC EDGAR
accession 0001193125-23-257803
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.